If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

Share Price is delayed by 15 minutes
Get Live Data
23.25    1.25 (5.68%)
Bid:
23.25
Ask:
23.50
Spread: 0.25 (1.075%)
Market Cap: £432.70m
ENQ Live PriceLast checked at - London Stock Exchange

Intraday Enquest Share Chart

Director/PDMR Shareholding

24 Dec 2014 12:10

RNS Number : 7491A
EnQuest PLC
24 December 2014
 



 

 

Director/PDMR holdings of securities

 

EnQuest PLC (the "Company")

24 December 2014

 

Notification of Transactions by

Persons Discharging Management Responsibility ('PDMRs').

 

Pursuant to the Company's obligations under Disclosure and Transparency Rule 3.1.4, the Company hereby notifies that the following Director purchased some of the Company's £155,000,000 5.50 per cent. Notes due 15 February 2022 (ISIN: XS0880578728, Common Code: 088057872) (together, the "Retail Notes").

 

Dr Philip Nolan notified the Company on 23 December 2014 that he had purchased 100,000 of the Retail Notes at 71 pence per Retail Note, totaling 0.065% of the total Retail Notes.  

 

Prior to this transaction, Dr Philip Nolan held 150,000 Ordinary Shares of £0.05 each in the Company ("Shares") and no Retail Notes. The total holding of Dr Philip Nolan following the transaction is 100,000 Retail Notes and 150,000 Shares.

 

 

Contact for enquiries:

 

EnQuest PLC

Stefan Ricketts

General Counsel and Company Secretary

020 7925 4900

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGMMZZZDKGDZM
Date   Source Headline
13th Apr 20234:54 pmRNSDirectorate Change
5th Apr 20237:00 amRNSResults for the year ended 31 December 2022
17th Mar 20237:00 amRNS2022 Preliminary Results - revised date
15th Mar 202311:00 amRNSHolding(s) in Company
17th Feb 20237:00 amRNSTrading Statement
20th Dec 20221:35 pmRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSChairman succession
24th Nov 20227:00 amRNSOperations Update
26th Oct 20227:00 amRNSSuccessful refinancing of capital structure
13th Oct 20227:00 amRNSPricing of new bond issue
16th Sep 20223:30 pmRNSDirector/PDMR
16th Sep 20223:00 pmRNSDirector/PDMR Shareholding
6th Sep 20227:00 amRNSHalf-year Report
30th Aug 20229:00 amRNSHolding(s) in Company
2nd Aug 20227:00 amRNSOperations Update
1st Aug 202212:33 pmRNSDirector/PDMR Shareholding
25th Jul 202210:28 amRNSDirector/PDMR Shareholding
22nd Jul 20222:46 pmRNSDirector/PDMR Shareholding
20th Jul 20222:04 pmRNSDirector/PDMR Shareholding
18th Jul 20224:11 pmRNSDirector/PDMR Shareholding
14th Jul 20224:46 pmRNSDirector/PDMR Shareholding
20th Jun 202210:33 amRNSDirector/PDMR Shareholding
17th Jun 20223:22 pmRNSAGM Statement
17th Jun 20227:00 amRNSBoard Change
15th Jun 202212:17 pmRNSDirector/PDMR Shareholding
14th Jun 20228:44 amRNSDirector/PDMR Shareholding
1st Jun 20224:57 pmRNSHolding(s) in Company
24th May 20224:42 pmRNSNotice of AGM
23rd May 20227:00 amRNSOperations update
29th Apr 20223:00 pmRNSReport on Payments to Govts
25th Apr 20223:38 pmRNSDirector/PDMR Shareholding
25th Apr 20223:00 pmRNSHolding(s) in Company
21st Apr 20227:00 amRNSIssue of Debt
14th Apr 20223:00 pmRNSHolding(s) in Company
11th Apr 20224:45 pmRNSHolding(s) in Company
30th Mar 20227:00 amRNSProspectus publication and launch of retail notes
30th Mar 20227:00 amRNSLaunch of exchange offer
24th Mar 20227:05 amRNSAnnual Financial Report
24th Mar 20227:01 amRNSResults for the year ended 31 December 2021
24th Mar 20227:00 amRNSDirectorate Change
15th Mar 20223:00 pmRNSHolding(s) in Company
11th Mar 20223:00 pmRNSHolding(s) in Company
10th Mar 20223:00 pmRNSHolding(s) in Company
2nd Mar 20223:00 pmRNSHolding(s) in Company
28th Feb 20223:00 pmRNSHolding(s) in Company
25th Feb 20223:00 pmRNSHolding(s) in Company
24th Feb 20223:00 pmRNSHolding(s) in Company
23rd Feb 20224:16 pmRNSHolding(s) in Company
17th Feb 20221:51 pmRNSHolding(s) in Company
16th Feb 20224:57 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.